Monsanto (MON) Misses Q3 EPS Views; Offers Informal Update on Bayer Proposal
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
- AMD gets bullish pre-earnings call from Lynx as server CPU demand accelerates
- Marathon Petroleum to sell two refineries to CVR Energy for $4.2B
- Moderna shares rise ahead of Thursday earnings report
- AMD forecast eases AI spending fears as data-center sales surge
- Broadcom shares climb as AI chip financing deal supports rally
- After-Hours Movers: AMD, SMCI, SWKS, NRIX, TOST, BKNG
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
Monsanto Reports Third Quarter Financial Results; Company Remains Innovation Partner of Choice, Securing Several Recent Technology and Operational Agreements
June 29, 2016 8:01 AM EDTCompany delivers FY16 Q3 as-reported EPS of $1.63, $2.17 on an ongoing EPS basis Full-year FY16 as-reported EPS guidance adjusted to $3.36 to $4.14 to reflect Argentine-related tax matters partially offset by a favorable change in the expected amount and timing of restructuring expense; anticipate being at low ends of as-reported range and ongoing EPS range of $4.40 to $5.10 given increased headwinds in Q3 Focus on strategic portfolio management and licensing commitments has led to several recent technology and operational agreements New technologies, platform... More



